Compare Danaher Corporation (DHR) vs 3M Company (MMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs 3M Company — how do they compare? Danaher Corporation trades at $197.72 (market cap $140.88B), while 3M Company trades at $156.2 (market cap $81.67B). The key difference: Danaher Corporation is the larger of the two by market cap, and 3M Company pays the higher dividend (1.99%). Which is the better fit depends on your goals.
| DHR | MMM | |
|---|---|---|
Market Cap | $140.88B | $81.67B |
Sector | Health | Industrials |
52-Week High | $242.05 | $174.61 |
52-Week Low | $161.91 | $141.10 |
Enterprise Value | $153.66B | $90.07B |
Dividend Yield | 0.8% | 1.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
3M (MMM) trades at $157.70, showing minimal daily movement with a 0.11% gain. The stock faces technical headwinds with bearish moving averages but maintains strong profitability metrics including a 72.14% ROE and consistent earnings beats. Recent developments include new product launches and strategic partnerships, though the company navigates consumer segment weakness and mixed analyst sentiment.
The outlook remains balanced with solid fundamentals supporting long-term value, but near-term risks include competitive pressures and macroeconomic sensitivity. Analyst consensus suggests cautious optimism with a $143 price target, while technical indicators signal potential consolidation around current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
